CDX cardiex limited
Add to My Watchlist 2.56% ! 4.0¢

Ann: CardieX Reports Successful Trial Results for Wearable Sensor, page-7

  1. lexcorp
    8,061 Posts.
    lightbulb Created with Sketch. 530
    clock Created with Sketch.
    24/07/18
    12:24
    Post #: 34535178
    Typical great result with the gold standard from cdx

    Next trial to be done in the USA and should be a massive re rate above 10c in August

    Been long for years and continue to be long
    CDX Price at posting: 3.8¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back
right-arrow Created with Sketch.
NEWS Strong Rock Chip Assays Include 18.4g/t Au from Waitekauri
right-arrow Created with Sketch.
NEWS 30,000m Diamond Drilling Commences at Napie Gold Project
right-arrow Created with Sketch.
ACW Actinogen Confirms 100th Participant in Alzheimer’s Disease Trial and Interim Analysis Timeline
right-arrow Created with Sketch.
NEWS Orthocell Announces First US Surgical Use of Remplir Following FDA Clearance
right-arrow Created with Sketch.
NEWS Proteomics International granted first patent for endometriosis diagnostic blood test in Japan
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
4.0¢ 		Change
0.001(2.56%) 		Mkt cap ! $22.00M
Open High Low Value Volume
4.0¢ 4.0¢ 4.0¢ $734 18.33K

Buyers (Bids)

No. Vol. Price($)
2 201661 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 2841 1
View Market Depth
Last trade - 13.16pm 30/06/2025 (20 minute delay) ?
CDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.